Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals

Biochemical and Biophysical Research Communications

Volumn 463, Issue 1-2, 2015, Pages 60-63

  Zhang, Tao ^a   Li, Liling ^a   Shang, Qingkun ^b   Lv, ChunFang ^a   Wang, ChangYi ^a   Su, Bing ^b,c  

^a Shenzhen Nanshan Center for Chronic Disease Control   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNA; MiR 126; Plasma; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; MICRORNA 126; MICRORNA 15A; MICRORNA 223; MICRORNA 29B; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GENETIC MARKER; MICRORNA; MIRN126 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; ALGORITHM; BLOOD; CASE CONTROL STUDY; CHINA; DIABETES MELLITUS, TYPE 2; DISEASE PREDISPOSITION; GENETIC MARKER; GENETICS; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; ALGORITHMS; BIOLOGICAL MARKERS; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; FEMALE; GENETIC MARKERS; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84934959756     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.05.017     Document Type: Article

References (26)

1. D.R. Whiting, L. Guariguata, C. Weil, J. Shaw, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res. Clin. Pract. 94 (2011) 311-321.
2. Y. Xu, L. Wang, J. He, Y. Bi, M. Li, T. Wang, L. Wang, Y. Jiang, M. Dai, J. Lu, M. Xu, Y. Li, N. Hu, J. Li, S. Mi, C.S. Chen, G. Li, Y. Mu, J. Zhao, L. Kong, J. Chen, S. Lai, W. Wang, W. Zhao, G. Ning, China Noncommunicable Disease Surveillance, Prevalence and control of diabetes in Chinese adults, JAMA 310 (2013) 948-959.
3. R.C. Ma, J.C. Chan, Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States, Ann. N. Y. Acad. Sci. 1281 (2013) 64-91.
4. W. Yang, J. Lu, J. Weng, W. Jia, L. Ji, J. Xiao, Z. Shan, J. Liu, H. Tian, Q. Ji, D. Zhu, J. Ge, L. Lin, L. Chen, X. Guo, Z. Zhao, Q. Li, Z. Zhou, G. Shan, J. He, China National Diabetes and Metabolic Disorders Study Group, Prevalence of diabetes among men and women in China, N. Engl. J. Med. 362 (2010) 1090-1101.
5. G. Roglic, N. Unwin, Mortality attributable to diabetes: estimates for the year 2010, Diabetes Res. Clin. Pract. 87 (2010) 15-19.
6. A. American Diabetes, Diagnosis and classification of diabetes mellitus, Diabetes Care 33 (Suppl. 1) (2010) S62-S69.
7. J.R. Prensner, A.M. Chinnaiyan, The emergence of lncRNAs in cancer biology, Cancer Discov. 1 (2011) 391-407.
8. M. Redova, J. Sana, O. Slaby, Circulating miRNAs as new blood-based biomarkers for solid cancers, Future Oncol. 9 (2013) 387-402.
9. Y.M. Pers, C. Jorgensen, MicroRNA in 2012: biotherapeutic potential of microRNAs in rheumatic diseases, Nat. Rev. Rheumatol. 9 (2013) 76-78.
10. D. Quiat, E.N. Olson, MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment, J. Clin. Invest. 123 (2013) 11-18.
11. C. Guay, R. Regazzi, Circulating microRNAs as novel biomarkers for diabetes mellitus, Nat. Rev. Endocrinol. 9 (2013) 513-521.
12. A. Allegra, A. Alonci, S. Campo, G. Penna, A. Petrungaro, D. Gerace, C. Musolino, Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review), Int. J. Oncol. 41 (2012) 1897-1912.
13. A.J. Tijsen, Y.M. Pinto, E.E. Creemers, Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases, Am. J. Physiol. Heart Circ. Physiol. 303 (2012) H1085-H1095.
14. S. Saal, S.J. Harvey, MicroRNAs and the kidney: coming of age, Curr. Opin. Nephrol. Hypertens. 18 (2009) 317-323.
15. A. Zampetaki, S. Kiechl, I. Drozdov, P. Willeit, U. Mayr, M. Prokopi, A. Mayr, S. Weger, F. Oberhollenzer, E. Bonora, A. Shah, J. Willeit, M. Mayr, Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes, Circ. Res. 107 (2010) 810-817.
16. C. Zhao, J. Dong, T. Jiang, Z. Shi, B. Yu, Y. Zhu, D. Chen, J. Xu, R. Huo, J. Dai, Y. Xia, S. Pan, Z. Hu, J. Sha, Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus, PLoS One 6 (2011) e23925.
17. T. Zhang, C. Lv, L. Li, S. Chen, S. Liu, C. Wang, B. Su, Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals, Biomed. Res. Int. 2013 (2013) 761617.
18. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan, Diabetes Prevention Program Research, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med. 346 (2002) 393-403.
19. M. Prentki, C.J. Nolan, Islet beta cell failure in type 2 diabetes, J. Clin. Invest. 116 (2006) 1802-1812.
20. B.C. Zyriax, R. Salazar, W. Hoeppner, E. Vettorazzi, C. Herder, E. Windler, The association of genetic markers for type 2 diabetes with prediabetic status -cross-sectional data of a diabetes prevention trial, PLoS One 8 (2013) e75807.
21. N. Kosaka, H. Iguchi, T. Ochiya, Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis, Cancer Sci. 101 (2010) 2087-2092.
22. E.M. Kroh, R.K. Parkin, P.S. Mitchell, M. Tewari, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods 50 (2010) 298-301.
23. M. Mraz, K. Malinova, J. Mayer, S. Pospisilova, MicroRNA isolation and stability in stored RNA samples, Biochem. Biophys. Res. Commun. 390 (2009) 1-4.
24. J.E. Fish, M.M. Santoro, S.U. Morton, S. Yu, R.F. Yeh, J.D. Wythe, K.N. Ivey, B.G. Bruneau, D.Y. Stainier, D. Srivastava, miR-126 regulates angiogenic signaling and vascular integrity, Dev. Cell. 15 (2008) 272-284.
25. Y. Liu, G. Gao, C. Yang, K. Zhou, B. Shen, H. Liang, X. Jiang, The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus, Int. J. Mol. Sci. 15 (2014) 10567-10577.
26. J.A. Kolberg, T. Jorgensen, R.W. Gerwien, S. Hamren, M.P. McKenna, E. Moler, M.W. Rowe, M.S. Urdea, X.M. Xu, T. Hansen, O. Pedersen, K. Borch-Johnsen, Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort, Diabetes Care 32 (2009) 1207-1212.